Cognitive-Behavioral Therapy Enhancement Strategies.


Journal

The Psychiatric clinics of North America
ISSN: 1558-3147
Titre abrégé: Psychiatr Clin North Am
Pays: United States
ID NLM: 7708110

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 9 5 2024
Statut: ppublish

Résumé

We review the literature on various strategies to augment cognitive-behavioral therapy (CBT). Although traditional pharmacotherapy has only a small additive effect, research demonstrates that it is possible to select interventions that potentiate known mechanisms of CBT. D-cycloserine appears to potentiate activity at the N-methyl D-ethyl aspartate receptor and thereby facilitates fear extinction. Exercise may increase neural plasticity and thereby increase the efficacy of CBT for depression and anxiety. Noninvasive brain stimulation is thought to target the specific cortical regions needed for CBT response, but results have been mixed. Several other compounds appear promising but await controlled research before their efficacy as an augmentation strategy can be determined.

Identifiants

pubmed: 38724125
pii: S0193-953X(24)00006-6
doi: 10.1016/j.psc.2024.02.005
pii:
doi:

Substances chimiques

Cycloserine 95IK5KI84Z

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-365

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure Dr D.F. Tolin receives royalties from Guilford Press, John Wiley and Sons, New Harbinger Publications, Oxford University Press, Cambridge University Press, and PsychWire. He is a consultant for Oui Therapeutics and Mindyra LLC. Drs K.A. Lord and K.A. Knowles have no potential conflicts to declare.

Auteurs

David F Tolin (DF)

The Institute of Living/Hartford Hospital, 200 Retreat Avenue, Hartford, CT 06106, USA; Yale University School of Medicine. Electronic address: david.tolin@hhchealth.org.

Kayla A Lord (KA)

The Institute of Living/Hartford Hospital, 200 Retreat Avenue, Hartford, CT 06106, USA.

Kelly A Knowles (KA)

The Institute of Living/Hartford Hospital, 200 Retreat Avenue, Hartford, CT 06106, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH